Home
AutoimmuneMedia
Autoimmune
-
Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies
Autoantibodies against myeloperoxidase (MPO), proteinase 3 (PR3), and glomerular basement membrane (GBM) are critical diagnostic markers for ANCA-associated vasculitides, microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), eosinophilic GPA (EGPA), and anti-GBM disease.
-
Clinical Performance of a Novel, Fully Automated Multiplexed Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies in ANCA-Associated Vasculitis and Anti-GBM Disease
Accurate and timely detection of anti-neutrophil cytoplasmic antibodies (ANCA)—specifically against myeloperoxidase (MPO)and proteinase 3 (PR3).
-
Diabetes Diagnostics: The Need for Advanced Autoimmune Testing
The global impact of type 1 and type 2 diabetes Diabetes is one of the pressing health challenges of our time. According to the International Diabetes Federation (IDF)[1], 589 million adults worldwide are living with diabetes. This number is projected
-
Transforming Vasculitis Diagnostics: Multiplex Microarray Solutions for PR3, MPO & GBM Autoantibodies
In–vitro diagnostics (IVD) is undergoing a transformation, driven by automation and a syndromic approach enabled by multiplexing technologies. At AliveDx, we’re proud to lead this evolution with the MosaiQ AiPlex® VAS microarray, a fully automated multiplex immunoassay designed to detect
-
Unlocking Comprehensive Insights in Autoimmune Diagnostics: The Role of Anti-DFS70 Autoantibodies
Autoimmune connective tissue diseases1 (CTD) such as lupus, Sjögren’s syndrome, and systemic sclerosis present a diagnostic challenge due to overlapping symptoms and complex antibody profiles. At AliveDx, we’re committed to the challenge of simplifying that complexity through innovative in-vitro diagnostic
-
Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis
Extended serological profiling may improve autoimmuneconnective tissue diseases (CTD) diagnosis.
-
Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 5 markers associated with Celiac Disease. ACG2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for autoantibodies associated with Celiac Disease. Presented at ACG 2024.
-
Performance characteristics of Automated Immunoassay Microarray prototype detecting Centromere Protein B (CENP-B). AACC2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies. Presented at AACC 2023.
-
Performance characteristics of Automated Immunoassay Microarray detecting Anti-Centromere Protein B antibodies. Immunochemistry & Immunopathology 2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies.
-
Performance characteristics of Automated Immunoassay Microarray prototype analyzing simultaneously 11 IgG markers associated with Connective Tissue Diseases. ACR2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting 11 IgG antibodies associated with Connective Tissue Diseases. Presented at ACR 2023.
